Susquehanna Fundamental Investments, LLC Beyond Spring Inc. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$10.61 - $15.77 $224,221 - $333,267	-21,133 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.21 - $17.31 $67,437 - $114,332	-6,605 Reduced 23.81%	21,133 $258,000
Q3 2020 Nov 16, 2020	BUY	$9.99 - $16.13 $277,102 - $447,413	27,738 New	27,738 $369,000

5.77M

53.2K

2.5K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $79.8M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.